Literature DB >> 19020777

Characteristic overexpression of the forkhead box transcription factor Foxf1 in Patched-associated tumors.

Danielle S Wendling1, Clemens Lück, Dietrich von Schweinitz, Roland Kappler.   

Abstract

Patients with nevoid basal cell carcinoma syndrome carry germline mutations in the tumor suppressor gene Patched 1 (PTCH1) and are predisposed to develop basal cell carcinoma (BCC), medulloblastoma (MB), and rhabdomyosarcoma (RMS). These tumors are also present in the murine model for Ptch1 deficiency, the Ptch1neo67/+ mouse. Previous studies, including those from our laboratory, have shown that the forkhead box transcription factor Foxf1 is highly expressed in RMS of human and murine origin. We report on a more common role of Foxf1 in Ptch1-associated tumorigenesis, since we found a striking up-regulation of Foxf1 expression in Ptch1-associated BCC and MB compared with the respective non-neoplastic tissue. This overexpression was accompanied by increased levels of the Hedgehog target gene Gli1 as well as the putative Foxf1 targets Bmi1 and Notch2 in these tumors. We also describe a striking Foxf1 activation in Ptch1 null embryos. In contrast, basal expression levels of Foxf1, Gli1, Bmi1 and Notch2 were detected in a variety of adult mouse tissues, such as liver, kidney, spleen, lung, heart and brain. In conclusion, our study suggests that Foxf1 expression is characteristically up-regulated in tumors with a constitutively activated Hedgehog signaling pathway thereby defining a key role for Foxf1 in Hedgehog-associated tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19020777

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  10 in total

1.  The gep proto-oncogene Gα12 mediates LPA-stimulated activation of CREB in ovarian cancer cells.

Authors:  Ji Hee Ha; Jeremy D Ward; Lakshmi Varadarajalu; Sang Geon Kim; Danny N Dhanasekaran
Journal:  Cell Signal       Date:  2013-09-19       Impact factor: 4.315

2.  FOXQ1 is overexpressed in laryngeal carcinoma and affects cell growth, cell cycle progression and cell invasion.

Authors:  Jie Zhang; Wei Li; Song Dai; Xuhui Tai; Jianping Jia; Xing Guo
Journal:  Oncol Lett       Date:  2015-07-23       Impact factor: 2.967

3.  Expression of Bmi1, FoxF1, Nanog, and γ-catenin in relation to hedgehog signaling pathway in human non-small-cell lung cancer.

Authors:  Ioannis P Gialmanidis; Vasiliki Bravou; Ilias Petrou; Helen Kourea; Alexandros Mathioudakis; Ioannis Lilis; Helen Papadaki
Journal:  Lung       Date:  2013-07-18       Impact factor: 2.584

4.  Genomic and Epigenetic Complexity of the FOXF1 Locus in 16q24.1: Implications for Development and Disease.

Authors:  Avinash V Dharmadhikari; Przemyslaw Szafranski; Vladimir V Kalinichenko; Pawel Stankiewicz
Journal:  Curr Genomics       Date:  2015-04       Impact factor: 2.236

5.  Forkhead transcription factor FoxF1 interacts with Fanconi anemia protein complexes to promote DNA damage response.

Authors:  Arun Pradhan; Vladimir Ustiyan; Yufang Zhang; Tanya V Kalin; Vladimir V Kalinichenko
Journal:  Oncotarget       Date:  2016-01-12

6.  Lethal lung hypoplasia and vascular defects in mice with conditional Foxf1 overexpression.

Authors:  Avinash V Dharmadhikari; Jenny J Sun; Krzysztof Gogolewski; Brandi L Carofino; Vladimir Ustiyan; Misty Hill; Tadeusz Majewski; Przemyslaw Szafranski; Monica J Justice; Russell S Ray; Mary E Dickinson; Vladimir V Kalinichenko; Anna Gambin; Paweł Stankiewicz
Journal:  Biol Open       Date:  2016-11-15       Impact factor: 2.422

Review 7.  The Emerging Roles of Forkhead Box (FOX) Proteins in Osteosarcoma.

Authors:  Wentao Zhang; Ning Duan; Tao Song; Zhong Li; Caiguo Zhang; Xun Chen
Journal:  J Cancer       Date:  2017-06-03       Impact factor: 4.207

8.  Comparative analyses of lung transcriptomes in patients with alveolar capillary dysplasia with misalignment of pulmonary veins and in foxf1 heterozygous knockout mice.

Authors:  Partha Sen; Avinash V Dharmadhikari; Tadeusz Majewski; Mahmoud A Mohammad; Tanya V Kalin; Joanna Zabielska; Xiaomeng Ren; Molly Bray; Hannah M Brown; Stephen Welty; Sundararajah Thevananther; Claire Langston; Przemyslaw Szafranski; Monica J Justice; Vladimir V Kalinichenko; Anna Gambin; John Belmont; Pawel Stankiewicz
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

9.  FoxF1 and FoxF2 transcription factors synergistically promote rhabdomyosarcoma carcinogenesis by repressing transcription of p21Cip1 CDK inhibitor.

Authors:  David Milewski; Arun Pradhan; Xinjian Wang; Yuqi Cai; Tien Le; Brian Turpin; Vladimir V Kalinichenko; Tanya V Kalin
Journal:  Oncogene       Date:  2016-07-18       Impact factor: 9.867

10.  Highly Expressed FOXF1 Inhibit Non-Small-Cell Lung Cancer Growth via Inducing Tumor Suppressor and G1-Phase Cell-Cycle Arrest.

Authors:  Chia-Yu Wu; Chun-Hao Chan; Navneet Kumar Dubey; Hong-Jian Wei; Jui-Hua Lu; Chun-Chao Chang; Hsin-Chung Cheng; Keng-Liang Ou; Win-Ping Deng
Journal:  Int J Mol Sci       Date:  2020-05-02       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.